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AbstrACt
Objectives Safe pharmaceutical care (PC) requires an 
interprofessional team approach, involving physicians, 
nurses and pharmacists. Nurses’ roles however, are not 
always explicit and clear, complicating interprofessional 
collaboration. The aim of this study is to describe nurses’ 
practice and interprofessional collaboration in PC, from the 
viewpoint of nurses, physicians and pharmacists.
Design A cross- sectional survey.
setting The study was conducted in 17 European 
countries, each with their own health systems.
Participants Pharmacists, physicians and nurses with an 
active role in PC were surveyed.
Main outcome measures Nurses’ involvement in 
PC, experiences of interprofessional collaboration and 
communication and views on nurses’ competences.
results A total of 4888 nurses, 974 physicians and 857 
pharmacists from 17 European countries responded. 
Providing patient education and information (PEI), 
monitoring medicines adherence (MMA), monitoring 
adverse/therapeutic effects (ME) and prescribing 
medicines were considered integral to nursing practice by 
78%, 73%, 69% and 15% of nurses, respectively. Most 
respondents were convinced that quality of PC would be 
improved by increasing nurses’ involvement in ME (95%), 
MMA (95%), PEI (91%) and prescribing (53%). Mean 
scores for the reported quality of collaboration between 
nurses and physicians, collaboration between nurses and 
pharmacists and interprofessional communication were 
respectively <7/10, ≤4/10, <6/10 for all four aspects of 
PC.
Conclusions ME, MMA, PEI and prescribing are part 
of nurses’ activities, and most healthcare professionals 
felt their involvement should be extended. Collaboration 
between nurses and physicians on PC is limited and 
between nurses and pharmacists even more.
IntrODuCtIOn
In 1990 pharmaceutical care (PC) was 
defined as the process through which a phar-
macist cooperates with a patient and other 
professionals in designing, implementing 
and monitoring a therapeutic plan that 
will produce specific therapeutic outcomes 
for the patient. This in turn involves three 
major functions: (1) identifying poten-
tial and actual drug- related problems, (2) 
resolving actual drug- related problems and 
(3) preventing potential drug- related prob-
lems.1 In other words, the responsibilities of 
the PC practitioner are to ensure that all of 
the medications being taken by the patient 
are appropriate, effective and safe, and can 
strengths and limitations of this study
 ► First pan- European survey of pharmaceutical care 
by nurses with insight into the current European 
situation.
 ► The large sample size with respondents from three 
professional groups from 17 European countries.
 ► Key elements of pharmaceutical care might be un-
derstood differently in different countries, due to 
differences in health systems across Europe, and 
collaborative development of a conceptual model 
and the questionnaire may not have overcome in-
consistencies in interpretation.
 ► The sample was self- selected with an unknown re-
sponse rate, which might have led to a distortion of 
the results due to only the most motivated profes-
sionals participating.
 ► The findings represent perceptions and are not vali-
dated against direct observations.
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be taken as intended.2 It is broadly recognised that there 
is a need for interprofessional collaboration in PC.3 4 
Ensing et al corroborated this in their systematic review 
identifying components of pharmacist interventions that 
can improve clinical outcomes during care transitions. 
They concluded that collaborating with other healthcare 
professionals is crucial to increase the effectiveness of 
pharmacist interventions.5
Nurses are healthcare professionals with significant 
responsibilities in PC. Dilles et al indicated that nurses 
regularly engage in pharmaceutical practice, such as 
providing information, monitoring treatment adher-
ence and recognising adverse drug reactions.6 Further-
more, many nurses are continuously in the immediate 
presence of patients, and therefore well- positioned 
to deliver PC.7–9 However, nurses experience a large 
number of barriers to safe PC related to medicines 
monitoring and interprofessional collaboration.6–10 
Moreover, nurses’ roles are not always explicit, distinct 
and clear to other professionals complicating interpro-
fessional collaboration.6
PC requires an interprofessional team approach, 
involving physicians, nurses and pharmacists.11 If nurses 
are able to raise concerns with physicians and pharma-
cists, this will help to reduce medication errors. Therefore, 
interprofessional interactions and open communication 
are essential for safe PC.11 12
An international comparative study in 39 countries, of 
which 35 were European, indicated a large variation in 
nurses’ roles. Clinical activities traditionally reserved for 
the medical profession were investigated. It was apparent 
that task shifting, where nurses, mostly with advanced 
training, take up advanced roles, such as prescribing 
medicines, was already implemented in 23 of 35 Euro-
pean countries, to maximise workforce capacity.13 PC 
activities of nurses, such as patient education, support, 
adherence monitoring and monitoring patients for 
potential adverse effects of medicines can be part of 
nursing practice throughout Europe. Evidence, however, 
is scarce. Also, in nurse education, a clear description of 
specific learning outcomes on PC appears to be absent 
in most European countries. Curricula covering PC 
vary considerably.5 13 Maier and Aiken state that devel-
oping minimum educational and practice standards 
may facilitate the comparability and recognition of 
advanced nursing roles across borders and in increas-
ingly connected labour markets.13
To our knowledge, there is no research available 
describing nurses’ roles in clinical practice in delivering 
PC from an interprofessional viewpoint throughout 
Europe. The aim of this study is to describe nurses’ prac-
tice and experiences on interprofessional collaboration 
with nurses in PC, from the viewpoint of nurses, physi-
cians and pharmacists, in different European countries. 
This study is abbreviated to EUPRON, an acronym for 
Europe, PC, roles of nurses.
MethODs
study design
In a quantitative, cross- sectional survey in 17 different 
European countries, nurses, physicians and pharmacists 
were invited to complete an online structured question-
naire on nurses’ practice in selected components of inter-
professional PC.
Participants and setting
Seventeen European countries participated in the study: 
Belgium, Czech Republic, England, Germany, Greece, 
Hungary, Italy, The Netherlands, Norway, Poland, 
Portugal, the Republic of North Macedonia, Slovakia, 
Slovenia, Spain, Sweden and Wales. Although England 
and Wales are both part of the UK, and not independent 
countries, they are mentioned separately because of their 
different healthcare systems.
Not all European countries participated because inclu-
sion in the project depended on the intrinsic motivation 
of researchers to join and collaborate in the project, 
since no funding resources were available at the start. 
In every country, local nurse researchers were contacted 
through international nurse associations. All nurse 
researchers collaborated in the project consortium by 
national recruitment of volunteer respondents and local 
data collection. Convenience sampling was used to select 
nurses, physicians and pharmacists, with an active role in 
PC for patients in a range of healthcare settings, such as 
hospitals, community care organisations, residential care 
settings and mental healthcare organisations. ‘Active’ 
was defined as currently working in clinical practice with 
patients.14 15 The term physician referred to all medical 
doctors, including surgeons, irrespective of specialty. 
Level 5–8 nurses of the European Qualification Frame-
work16 (vocational, associate, bachelor, master or PhD 
nurses) were eligible, whereas professionals without regis-
tered nursing status or in training, and students were 
excluded.
survey development
Based on literature, a conceptual model about nurses’ 
practice in interprofessional PC was developed (online 
supplementary figure 1). This conceptual model was 
validated (face validity) by the project consortium of 
researchers to ensure the fit with local context. After-
wards, based on the model, an English language question-
naire was developed by the consortium of international 
experts and evaluated and adjusted until consensus was 
reached (online supplementary material). Following 
questions on demographics, employment and education, 
four aspects of PC were addressed: monitoring adverse/
therapeutic effects of medicines (ME), monitoring medi-
cines adherence (MMA), prescribing and providing 
patient education and information about medicines 
(PEI). The perceived quality of collaboration between 
nurses and physicians and between nurses and pharma-
cists, the perceived quality of nurses’ competences and 
the perceived quality of interprofessional communication 
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on the different aspects of PC were rated with a score of 
0–10 (0=low quality, 10=high quality). The four domains 
addressed, are part of PC, yet, other responsibilities and 
tasks could be defined within the concept of PC.1 2 The 
main content of the questionnaire was the same for 
nurses, physicians and pharmacists. However, while nurses 
were questioned about their own practice, physicians 
and pharmacists were questioned about nurses’ practice. 
The questionnaire was translated into all languages of 
the participating countries by voluntary and sworn trans-
lators. The nurse researchers were asked to check the 
translation in their own language, and the completion 
time. Finally, the instrument was piloted with the group 
of international researchers as to its applicability and 
comparability in different health system contexts.
Patient and public involvement
The study participants included pharmacists, physi-
cians and nurses. Since the study focused on healthcare 
providers, patients and the public were not involved in 
this study.
Data collection
We aimed to reach a representative sample of nurses, 
physicians and pharmacists in each country. Between 
December 2017 and June 2018, institutions and organ-
isations were asked to distribute the questionnaire and 
send reminders. Each partner looked for the optimum 
distribution strategy, depending on local possibilities 
(existing organisations and networks). A weblink to the 
questionnaire was sent by email to key stakeholders, 
professional associations, healthcare facilities and private 
professional networks. Sampling efforts focused on 
nurses, pharmacists and physicians. Nursing faculties as 
well as interprofessional colleagues (Faculty of Medicine 
and Faculty of Pharmacy) initiated sampling. All contacts 
were additionally asked to forward the link to colleagues, 
eligible to participate. The weblink was placed on univer-
sity websites, webpages of professional associations and 
on social media. Each country received regular updates 
about the number of participants.
Data analysis
Data were analysed using IBM SPSS Statistics V.24.0. A 
two- sided level of significance of 0.05 was used. Discontin-
uous data were described using frequency distributions; 
continuous data were described using a mean value and 
an SD. Normality of the distribution was tested with the 
absolute values of the skewness and kurtosis because of 
the large sample size.17 All data were normally distributed. 
Differences in opinion by nurses, physicians and pharma-
cists were explored. To evaluate the statistical significance 
of the differences between the three professional groups, 
χ2 test for dichotomous variables, one- way analysis of vari-
ance (Bonferroni post hoc test) for scale variables and 
Kruskal- Wallis for ordinal variables were used. Repre-
sentativity of the sample size per country was shown by a 
ratio, calculated as: the number of respondents in each 
country divided by the approximate number of inhabi-
tants in that country multiplied by 100 000.18 The number 
of inhabitants per country was chosen to represent the 
country size, since approximate numbers of nurses, physi-
cians and pharmacists were not available for all countries.
ethical considerations
All respondents received information on the purpose, 
design and execution of the study. Before the digital ques-
tionnaire could be started, all respondents had to indi-
cate they had read the study information and consented 
to participate. Data were collected anonymously to ensure 
privacy.19
results
research population
A total of 6719 respondents participated, of whom 73% 
were nurses, 14% physicians and 13% pharmacists. Across 
the 17 countries, the number of respondents per 100 000 
inhabitants varied from 0.1 to 36.4. Mean age was 42 years 
and 78% of the population was female. The majority of 
the respondents worked in a hospital (61%) and worked 
together with one or more nurses and with one or more 
physicians. Collaboration with one or more pharmacists 
was reported by 90% of the pharmacists but only 39% of 
the nurses and 42% of the physicians. More than half of 
the respondents reported that interprofessional PC was 
encouraged by their employer’s policies. Forty per cent 
of the nurses had a level 6 post (European Qualifica-
tion Framework) and 48% had attended specific extra 
educational activities focusing on PC after obtaining their 
nursing qualification. More detailed population charac-
teristics are presented in table 1.
Monitoring adverse/therapeutic effects of medicines
Almost 70% of the nurse respondents had been involved 
in ME in the last month, with a higher prevalence of 
ME as the level of education decreased (table 2). Across 
Europe, the proportion of respondents considering ME 
as part of nurses’ roles, varied from 72% to 98% (online 
supplementary figure 2). More healthcare workers in 
non- ambulatory settings and professionals already collab-
orating with other professions were convinced of this 
(respectively, 90% vs 82%, p<0.001, online supplemen-
tary table 1, and 88% vs 55%, p<0.001, online supplemen-
tary table 2). Pharmacists were significantly less likely to 
recognise ME as part of nurses’ roles (p<0.001, table 3).
Almost all respondents (95%) were convinced of the 
positive impact of nurses’ involvement in ME on the 
quality of PC (86%–98% across Europe) (online supple-
mentary figure 3). Two- thirds of respondents believed 
that the involvement of nurses in ME should be extended 
(table 3).
Monitoring medicines adherence
MMA was reported as part of nursing practice in the last 
month by 73% of nurses. In nurses with lower levels of 
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Table 1 Population characteristics (n=6719)
All respondents
(n=6719)
Nurses
(n=4888)
Physicians
(n=974)
Pharmacists
(n=857)
Demographical data n (%) % % %
Country (respondents/100 000 
inhabitants*, n)
        
  Slovenia (36.4) 753 (11.2) 11.5 16.7 3
  Slovakia (16.6) 902 (13.4) 11 11.6 29.2
  Norway (9.0) 479 (7.1) 6.2 6.8 12.6
  Belgium (8.7) 992 (14.8) 11.8 23.3 22.1
  Czech Republic (8.2) 868 (12.9) 15.1 8.4 5.5
  Wales (6.5) 202 (3.0) 2.9 1.1 5.6
  North Macedonia (6.5) 134 (2.0) 1.7 3 2.6
  Hungary (3.8) 376 (5.6) 6.3 5.5 1.6
  Sweden (2.5) 256 (3.8) 3 3.2 9
  Greece (2.4) 256 (3.8) 4.6 2.6 0.6
  Portugal (1,3) 130 (1.9) 2.3 1.4 0.7
  The Netherlands (0.8) 134 (1.8) 2.2 1.1 0.2
  Germany (0.7) 584 (8.7) 11.3 0.3 3.2
  Italy (0.6) 341 (5.1) 4.7 10.8 0.5
  UK (0.5) 336 (5.0) 5 2.2 8.5
  Poland (0.4) 167 (2.5) 2.7 3 0.6
  England (0.2) 34 (2.0) 2 1 2.9
  Spain (0.1) 25 (0.4) 0.5 0.1 0.2
Gender (female) 5242 (78.2) 83.3 53.2 77.6
Age (years), mean (min- max) 42.0 (21–77) 41.8 (21–75) 45.1 (24–75) 39.5 (23–77)
Job characteristics % % % %
Area of CP         
  Hospital 61.1 66.5 67.6 30.1
  Community or primary care 18.9 16.5 19.2 44.2
  Residential care 7.3 9.5 5.8 1.4
  Educational setting 0.1 0.4 0.3 0
  Other 12.5 7.1 7.1 23.6
Work experience in healthcare 
(years), mean (SD)
18.0 (12.0) 11.8 12.8 11.5
Main patient population to take 
care for
        
  Children (0–17 years) 7.3 7.2 7.7 Pharmacists not 
questioned  Adults (18–64 years) 25.7 25.7 25.7
  Older persons (≥65 years) 18.7 19.7 13.5
  More than one age group 48.3 47.4 53
Domains/roles†         
  CP/direct patient care 100 100 100 100
  Research 37.2 38.8 39 28.9
  Management 61.4 68.5 38.2 52.4
  Education 52.9 58.4 44.2 40.2
Working in CP (hours/week), 
mean (SD)
12.4 11.6 13.7 12.2
Continued
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All respondents
(n=6719)
Nurses
(n=4888)
Physicians
(n=974)
Pharmacists
(n=857)
Number of nurse co- workers in 
daily CP
        
  None 7.7 4.5 5.3 33.3
  <5 44.9 47.3 39.3 36.4
  5–10 26.1 27.5 26.9 15.4
  >10 21.3 20.8 28.4 15
Number of medical co- workers 
in daily CP
        
  None 8.4 5.7 6.8 29.1
  <5 58.8 63.9 46.9 41.3
  5–10 21.1 20.7 27.1 16
  >10 11.7 9.8 19.3 13.6
Number of pharmacist co- 
workers in daily CP
        
  None 54.7 61.4 58.3 10.1
  <5 39.9 36.5 37.6 63.3
  5–10 3.6 1.5 3.2 17
  >10 1.7 0.6 0.9 9.6
Availability of physician to 
discuss patients’
MM rated as good
  
  
  
  
  
  
  
  
  (Strongly) agree Only nurses 
questioned
84.4     
  (Strongly) disagree 13.8     
  Do not know 1.8     
Availability of pharmacists to 
discuss patients’
MM rated as good
  
  
  
  
  
  
  
  
  (Strongly) agree Only nurses 
questioned
59.5     
  (Strongly) disagree 24.3     
  Do not know 16.2     
Education % % % %
Highest educational level (EQF)         
  5 Only nurses 
questioned
  
  
  
33.4     
  6 40.4     
  7 22.8     
  8 3.3     
Time spend on non- mandatory 
extra education
        
  >2 days/year 77 74.1 89 80.1
  1–2 days/year 15.7 17.7 7 14.2
  <1 day/year 4.6 5.1 2.3 4.6
  No time spent 2.7 3.2 1.7 1
Specific extra educational 
activities focusing
on PC or optimisation since 
obtaining
nursing qualification
  
Only nurses 
questioned
  
47.7
  
  
  
  
  
  
Table 1 Continued
Continued
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All respondents
(n=6719)
Nurses
(n=4888)
Physicians
(n=974)
Pharmacists
(n=857)
Interprofessional MM is 
encouraged by
employers’ policies
  
  
  
  
  
  
  
  
  (Strongly) agree 58.8 56.2 58 76
  (Strongly) disagree 25.3 27.8 21.9 13.5
  Do not know 15.9 16 20 10.6
*The number of persons having their usual residence in a country on 1 January 2018. Number of inhabitants was chosen to represent the 
country size, since the approximate number of nurses, physicians and pharmacists was not available for all countries.15
†More than one answer possible.
CP, clinical practice; EQF, European Qualifications Framework14; MM, medicines management; PC, pharmaceutical care.
Table 1 Continued
education, MMA was significantly more a part of their 
activities than in nurses with higher educational levels 
(table 2). Pharmacists, healthcare workers in ambulatory 
settings and professionals who did not collaborate with 
nurses were less likely to recognise MMA as part of nurses’ 
roles (table 3, online supplementary table 1 and online 
supplementary table 2). In Hungary, 31% of the respon-
dents considered MMA as part of nurses’ role, while across 
the rest of Europe this varied from 82% to 98% (online 
supplementary figure 2). Almost all respondents (95%) 
were convinced of the positive impact of nurses’ involve-
ment in MMA on the quality of PC (89%–100% across 
Europe) (online supplementary figure 3). According to 
65% of respondents, the involvement of nurses in MMA 
should be extended. However, nurses were less convinced 
(63%) of the need to extend their involvement than physi-
cians (70%) and pharmacists (71%) (p<0.001) (table 3).
Prescribing medicines
Nurse prescribing was the aspect of PC least likely to be 
reported as part of nursing practice in the last month 
(15%; with a range across Europe from 7% to 30%) 
(figure 1, table 2). No difference in educational level 
existed. Almost one- third of the nurses stated prescribing 
was a part of their role, which was significantly more 
than physicians’ (p<0.001) and pharmacists’ (p<0.001) 
(table 3). Professionals working in primary or commu-
nity care and professionals collaborating with nurses were 
more likely to evaluate prescribing as part of nurses’ roles 
(respectively 32% vs 27%, p=0.008, online supplementary 
table 1 and 28% vs 13%, p<0.001, online supplemen-
tary table 2). Across Europe, the proportion of respon-
dents acknowledging prescribing as part of nurses’ roles 
differed: from 11% in Germany to 52% in Wales and 
81% in The Republic of North Macedonia (p<0.001) 
(online supplementary figure 2). However, at the time of 
data collection only England, The Netherlands, Poland, 
Sweden and Wales had legislation in place for non- medical 
prescribing, usually restricted to specialised nurses and/
or certain medicines. More nurses (60%) were convinced 
of the positive impact of nurse involvement in prescribing 
medicines on the quality of PC than physicians (39%) or 
pharmacists (29%) (p<0.001). Across Europe, between 
35% and 75% of respondents felt that nurse prescribing 
had a positive impact on care quality (online supplemen-
tary figure 3). More than half of all nurses thought their 
involvement in prescribing should be extended, which 
was significantly higher than physicians (29%, p<0.001) 
and pharmacists (23%, p<0.001) (table 3).
Providing patient education and information about medicines
More than three- quarters of the nurses reported PEI as 
part of their practice in the last month, with more PEI 
activities as the level of education decreased (table 2). 
Across Europe, the proportion of respondents that 
acknowledged PEI as part of nurses’ roles, varied from 
55% to 93% (online supplementary figure 2). Pharma-
cists and professionals who did not collaborate with 
nurses were significantly less likely to consider PEI as part 
of nurses’ roles (p<0.001). Almost all respondents (91%) 
were convinced of the positive impact of nurse involve-
ment in PEI on the quality of PC (table 3). This ranged 
from 81% to 100% across Europe (online supplementary 
figure 3). Two- thirds of the respondents believed that 
the involvement of nurses in PEI should be extended 
(table 3).
Quality of interprofessional collaboration, interprofessional 
communication and nurses’ competences in PC
The mean reported perceived quality of collaboration 
between nurses and physicians on ME, MMA, prescribing 
and PEI varied from 5.9/10 to 6.6/10. Between nurses 
and pharmacists scores were lower (3.6/10–4/10). Profes-
sionals who already collaborated interprofessionally, 
rated the quality of collaboration more highly than non- 
collaborating professionals (online supplementary table 
2). These ‘collaborating’ professionals were also more 
likely to consider ME, MMA, prescribing and PEI as part 
of nurses’ roles and to acknowledge the positive impact 
of nurse involvement in PC. Detailed comparisons can 
be found in online supplementary table 2. Nurses rated 
their own competence on a self- rating scale more highly 
(4.8/10–7.1/10) than did physicians (4.0/10–6.3/10) 
and pharmacists (3.7/10–5.2/10) (figure 2). The scores 
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Table 2 Nurses’ self- reported prevalence of different aspects of pharmaceutical care (PC) and reported actions or opinions 
concerning PC, split up for the different educational levels
Monitoring adverse/therapeutic effects
% of all 
nurses
% of level 5 
nurses
(n=1570)
% of level 6 
nurses
(n=1897)
% of level 7 
nurses
(n=1072)
% of level 
8 nurses
(n=156) P value
Part of activities last month 69.1 74.2 70.8 61.2 52.6 <0.001
Actions after observing an adverse effect*   
  Discussed with a physician 90.1 90.1 89.3 91.7 88.9 0.194
  Discussed with a pharmacist 7.6 6.8 7.5 7.9 14.4 0.009
  Discussed with a nurse 43.6 44.7 44.7 40.5 41.2 0.108
  Discussed with the patient 39.1 40.2 39.3 37 39.2 0.438
  Reported in the patient file 61.2 66.6 58.9 58.2 56.2 <0.001
  Intervened on own initiative 28.4 29.9 24.5 32.8 30.1 <0.001
  Nothing 0.1 0.2 0.1 0.1 0 0.821
  Never observed an adverse effect 4.1 3.5 4.9 3.5 3.3 0.108
Monitoring medicines adherence %
Part of activities last month 73 82.7 70.6 66.3 53 <0.001
Actions after observing non- adherence*   
  Discussed with a physician 83.5 86 81.6 83.3 84.4 0.016
  Discussed with a pharmacist 5 3.7 5.2 5.4 10.9 0.001
  Discussed with a nurse 43.7 44.5 44.8 41 41.5 0.232
  Discussed with the patient 58.5 61.8 56 58.6 55.8 0.014
  Reported in patient file 60.4 68 56.4 57.8 53.1 <0.001
  Intervened on own initiative 16.8 19.2 13.7 18.2 19.7 <0.001
  Nothing 0.4 0.3 0.4 0.6 0 0.502
  Never observed non- adherence 6.7 5.3 8 7.2 5.4 0.026
Prescribing medicines %
Part of activities last month 14.9 13.7 15.3 15.6 18.2 0.364
Actions after observing inappropriate 
prescribing by any professional*
  
  Discussed with a physician 78.2 81.5 73.4 81.6 78.9 <0.001
  Discussed with a pharmacist 8.2 6.5 8.8 8.7 14.3 0.007
  Discussed with a nurse 35.8 38.2 34.5 34.3 39.1 0.137
  Discussed with the patient 16.9 18.6 15.1 17.3 18 0.091
  Reported in the patient file 26.3 32 23.3 23.9 25.6 <0.001
  Intervened on own initiative 13.8 17.2 10.8 14.2 15.8 <0.001
  Nothing 0.3 0.2 0.3 0.2 0.8 0.586
  Never noticed inappropriate prescribing 17.9 15.9 22.2 14.3 9.8 <0.001
Providing patient education and 
information about medicines (PEI)
%
Part of activities last month 78.1 81.2 77.4 76.1 71.1 0.004
Nurse opinions concerning PEI*   
  Pharmacists, physicians, nurses were well 
aware of PEI by each team member
20.1 16.1 21.6 23.6 17.3 0.021
  Feeling qualified to PEI 36.6 34.8 37.5 36.4 46.2 0.379
  Enough information of physician to PEI 39 21.9 20.7 14.1 11.5 0.008
  Other professions would have given better 
PEI
20 16.4 12.4 12.3 9.6 0.116
*More than one answer possible; p values were calculated with χ2 test for the difference between educational levels, p<0.05 are in bold.
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Table 3 Nurse involvement in four aspects of pharmaceutical care from the viewpoint of nurses, physicians and pharmacists
Nurses’ 
viewpoint
(n=4888)
Physicians’ 
viewpoint
(n=974)
Pharmacists’ 
viewpoint
(n=857)
Overall 
viewpoint
(n=6719)
Monitoring adverse/therapeutic effects (ME)* % % % %
Part of nurses’ role 93 73 62.9 81.2
Convinced of positive impact of nurse involvement on PC 95.9 92.6 88 94.5
Involvement of nurses in ME should:         
  Be extended 68.2 69.5 69.2 68.5
  Remain the same 29.9 28.2 24.8 29
  Be restricted 1.9 2.3 6 2.4
Monitoring medicines adherence (MMA)* % % % %
Part of nurses’ role 94.7 84 75.8 85.2
Convinced of positive impact of nurse involvement on PC 95.7 93.6 90.5 94.8
Involvement of nurses in MMA should:         
  Be extended 63.4 69.6 71.2 65.2
  Remain the same 35.2 28.8 24.8 33
  Be restricted 1.4 1.6 4 1.8
Prescribing medicines* % % % %
Part of nurses’ role 30.3 22.1 21.3 23.1
Convinced of positive impact of nurse involvement on PC 60.1 38.9 29.3 53.3
Involvement of nurses in prescribing medicines should be:         
  Extended 54.6 28.9 22.8 46.9
  Remain the same 32.2 49.4 37.9 35.6
  Restricted 13.2 21.7 39.3 17.4
Providing patient education/information about 
medicines (PEI)*
% % % %
Part of nurses’ role 86.3 68.2 64.5 76.7
Convinced of positive impact of nurse involvement on PC 93.3 85.1 80.2 90.6
Involvement of nurses in PEI should be:         
  Extended 68.5 63.8 58.9 66.7
  Remain the same 28.9 30.9 29.8 29.3
  Restricted 2.6 5.3 11.3 4
*Viewpoint of nurses, physicians, pharmacists was significantly different (p<0.001) for all variables except for ‘involvement of nurses 
in ME should be extended/remain the same/be restricted’ (p=0.775). P value was calculated with χ2 test for ‘part of nurses’ role’ and 
‘convinced of positive impact’ and Kruskal- Wallis test for ‘nurse involvement should be extended/remain the same/be restricted’.
for the reported quality of interprofessional communica-
tion varied from 5.0/10 to 5.7/10. Here, pharmacists gave 
a significantly lower score (4.3/10–4.5/10) than nurses 
(5.1–5.9/10) and physicians (4.9/10–5.7/10) (figure 3). 
More detailed scores across Europe are presented in 
online supplementary figures 4–7.
DIsCussIOn
The EUPRON data clearly describe nurses’ routine clin-
ical practice in PC. Although some variation is apparent, 
the differences between the 17 countries in practice, 
competence, collaboration and communication in PC are 
not as large as expected.
We investigated four different PC activities. Most nurses 
were actively involved in ME, PEI and MMA the last month, 
particularly the nurses with lower educational attainment. 
Nearly all nurses, physicians and pharmacists believed 
nurse involvement positively impacted on the quality of 
PC. Also, most nurses, physicians and pharmacists were 
convinced ME, PEI and MMA are part of nurses’ role. 
Moreover, an extension of nurses’ roles in ME, PEI, MMA 
was proposed by two- thirds of respondents. However, 
scores were suboptimal in all four different aspects of PC 
for the quality of: nurses’ competences, collaboration of 
nurses with physicians or pharmacists and interprofes-
sional communication.
The lowest ratings for collaboration related to nurse- 
pharmacist working. This may reflect the observation 
that pharmacists were the least frequently mentioned 
co- workers in clinical practice, and this lack of familiarity 
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Figure 1 Percentages of nurses stating that prescribing 
medicines was part of their activities last month, by country 
and across Europe as a whole. P values was calculated with 
χ2 test.
Figure 2 Mean scores (on 10) for the reported self- 
perceived quality of nurse competences in pharmaceutical 
care (split up for four aspects), from the viewpoint of nurses, 
physicians and pharmacists. *P<0.05 for the difference in 
mean quality score between nurses/physicians/pharmacists 
(overall comparison, one- way analysis of variance); †p<0.05 
for the difference in mean quality score between nurses and 
physicians (pair- wise comparison, Bonferroni post hoc test); 
‡p<0.05 for the difference in mean quality score between 
nurses and pharmacists (pair- wise comparison, Bonferroni 
post hoc test); §p<0.05 for the difference in mean quality 
score between physicians and pharmacists (pair- wise 
comparison, Bonferroni post hoc test).
Figure 3 Score (on 10) for the reported self- perceived 
quality of collaboration between nurses and physicians, 
collaboration between nurses and pharmacists and 
interprofessional communication in pharmaceutical care 
(split up for four aspects), from the viewpoint of nurses, 
physicians and pharmacists. *P<0.05 for the difference in 
mean quality score between nurses/physicians/pharmacists 
(overall comparison, one- way analysis of variance); †p<0.05 
for the difference in mean quality score between nurses and 
physicians (pair- wise comparison, Bonferroni post hoc test); 
‡p<0.05 for the difference in mean quality score between 
nurses and pharmacists (pair- wise comparison, Bonferroni 
post hoc test); §p<0.05 for the difference in mean quality 
score between physicians and pharmacists (pair- wise 
comparison, Bonferroni post hoc test).
might have influenced pharmacists’ perceptions of 
nurses’ practice. After all, it is more difficult to under-
stand another professionals’ role, when not working 
directly with them. The literature on nurse- pharmacist 
collaborations is contradictory. A study in Pakistan found 
poor collaboration between nurses and pharmacists: 24% 
of the nurse study population (n=220) never or rarely 
interacted with a pharmacist.20 A Chinese study found 
positive attitudes towards nurse- pharmacist collabora-
tion, even though there was still room for improvement 
and American research showed nurse- pharmacist collab-
oration was efficient and cost‐effective, which improved 
patient safety.21 22 In Europe, there is little recent research 
on nurse- pharmacist collaboration. A UK study reported 
limited contact between community pharmacists and 
nurse prescribers, in contrast to the reported frequency 
of contact with other healthcare professionals. Yet, there 
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are positive views on pharmacist- nurse team- working.23 A 
recent review by Celio et al in European as well as non- 
European countries concluded pharmacist- nurse medi-
cation adherence- enhancing interventions are rare and 
often in the nascent phase.24
Our findings on nurse prescribing were surprising: 
prevalence was much higher than expected, based on the 
legislation in the participating countries. Only The Neth-
erlands, Poland, Sweden and the UK legally permitted 
nurse prescribing at the time of data collection.13 However, 
in all other countries some nurses indicated having 
prescribed the last month. In addition, one- quarter of the 
nurses, physicians and pharmacists believed prescribing 
was part of nurses’ role, with up to 81% in The Republic of 
North Macedonia, where nurse prescribing is not legally 
allowed. After discussing these results within the research 
consortium, the experts concluded the term ‘prescribing’ 
might have been interpreted by respondents as selecting 
and applying medicinal products for wound care. Another 
possibility is that prescribing was not legally allowed, 
yet performed by nurses in an informal, unofficial way. 
Maier and Aiken described how prescriptive authority 
by nurses can vary from no authority to a limited or a 
broad range of activities officially authorised.13 In some 
countries, nurses are allowed to prescribe a wide range 
of medicines within certain specialties. Levels of inde-
pendence range from fully independent to various forms 
of physician oversight, depending on types of medicines 
and country- specific governance structures. The study 
of Maier and Aiken in 39 countries, of which 35 Euro-
pean, indicated task shifting from physicians to nurses, 
for example, prescribing by nurses, has become common 
in many countries.13
This study showed lower educated nurses were more 
likely to monitor patients for adverse/therapeutic effects 
and medication adherence and provided more patient 
education/information. Our results partly correspond to 
a previous study of Dilles et al on nurses’ practice in PC 
and association with educational level (diploma vs bach-
elor nurse). There, more diploma nurses observed non- 
adherence, yet more bachelor nurses observed adverse 
drug reactions. No differences for providing patient 
education/information were shown.6
The results in this study showed nurses are willing to 
extend their involvement in all areas of PC. This suggests 
nurses believe PC is the responsibility of teams in which 
they are included. While nurses favoured an expansion of 
their involvement in prescribing, this was not supported 
by pharmacists. On the contrary, 39% were in favour of 
restricting nurses’ involvement.
Although most nurses were performing several activi-
ties of PC, and consequently taking responsibility in parts 
of PC, our findings show nurses’ competences in PC were 
reported as rather low. The lack of clarity in nurses’ roles 
in PC can contribute to nurses not receiving sufficient 
training in different aspects of PC. A clear definition of 
roles however, is a fundamental prerequisite for effective 
education and collaboration among nurses, physicians 
and pharmacists, for delivering safe care to patients and 
meeting patients’ needs.24 Effective team communication 
and better training in interprofessional collaboration is 
needed to tackle adverse patient events.25–31 Therefore, 
nurse education curricula as well as the curricula of all 
other disciplines need to address these weaknesses.32
strengths and limitations
This study is unique because of its large sample size and 
diversity, consisting of respondents of three professional 
groups from 7 European countries. To our knowledge, 
this is the first pan- European survey of PC by nurses. 
Despite the limited number of participants at the national 
level, the overall data provided interesting first insight in 
the current European situation.
This internet survey had limitations. The inclusion or 
exclusion of countries and respondents was determined 
by whether they agreed or declined to participate in the 
study. This self- selected sample with an unknown response 
rate might have led to a distortion of the results due to 
only the most motivated professionals participating. 
Also, the sample favoured more educated computer- 
literate professionals, due to use of internet recruitment. 
Another limitation that needs to be taken into account 
when interpreting the results is the differences in health 
systems across Europe. Despite the conceptual model and 
international collaboration in the questionnaire develop-
ment, key elements of PC might be understood differ-
ently, as discussed for the term ‘prescribing’. Finally, we 
acknowledge that our findings represent perceptions and 
are not validated against direct observations or correlated 
with any outcomes.
Implications and recommendations for practice and research
Because of the descriptive nature of this survey, few asso-
ciations were explored. Differences exist, for example, 
in area of clinical practice or educational attainment. 
Further research, zooming in on possible associations, is 
needed to highlight these differences and identify areas 
of greatest need.
The EUPRON data demonstrated that throughout 
Europe, nurses’ contribution to interprofessional PC is 
not transparent and differs between countries, in both 
law and practice. The lack of transparency and recog-
nition, combined with international variation, in both 
nursing practice and education, can hinder collabo-
ration on different levels: quality of interprofessional 
communication and collaboration in daily clinical prac-
tice; transnational collaboration in research, education 
and innovation across Europe and labour mobility of 
nursing students and nurses. Further research is needed 
to explore whether the level of education and practice 
variation is associated with variation in patient outcomes, 
particularly in terms of medication errors, the prevalence 
of adverse effects and hospitalisation for adverse effects.
In EUPRON, we decided to use a quantitative study 
design to investigate the current clinical practice of nurses 
in PC. Insights in the strengths and weaknesses of nurses’ 
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practice today, and in the opportunities and threats for 
the future cannot be extracted out of the EUPRON data. 
An in- depth qualitative study in all partner countries, 
interviewing nurses, physicians and pharmacists, would 
create a strengths, weaknesses, opportunities and threats 
(SWOT) analysis on nurses’ roles in interprofessional 
PC in the different countries, and in Europe as a whole. 
This would allow learning about good practice, and the 
prerequisites for patient safety, which can then form 
the basis for development of a model for nurses’ roles 
in interprofessional PC. Subsequently, this model could 
be a framework for interprofessional collaboration in 
clinical practice, education, transnational collaboration 
in research in Europe and labour mobility of nurses and 
nursing students.
COnClusIOn
Monitoring adverse/therapeutic effects of medicines, 
monitoring medicines adherence, prescribing medicines 
and providing patient education and information about 
medicines are part of the activities of nurses in clinical 
practice. Healthcare professionals felt that nurse involve-
ment should be extended. The quality of collaboration 
between nurses and physicians on pharmaceutical care is 
limited and between nurses and pharmacists even more 
so.
Author affiliations
1Nursing and Midwifery, Faculty of Medicine and Health Sciences, University of 
Antwerp, Wilrijk, Belgium
2Higher School of Nursing of Coimbra Health Sciences Research Unit Nursing, 
Coimbra, Portugal
3Department of Neurobiology Care Sciences and Society, Karolinska Institutet, 
Huddinge, Sweden
4Department of Clinical Nursing, Medical University of Warsaw, Warsaw, Poland
5ANASTE- Humanitas Foundation, Rome, Italy
6Research Group Care for the Chronically Ill, HU University of Applied Sciences 
Utrecht, Utrecht, The Netherlands
7Saint Kliment Ohridski University Bitola, Bitola, Bitola, The former Yugoslav 
Republic of Macedonia
8Faculty of Health and Welfare, Østfold University College, Halden, Norway
9Institute of Nursing Theory and Practice, Charles University First Faculty of 
Medicine, Praha, Czech Republic
10Deutsches Institut für angewandte Pflegeforschung e V, Köln, Germany
11Nursing, Swansea University, Swansea, UK
12Department of Nursing, University of Primorska College of Health Care, Izola, 
Slovenia
13Department of Nursing and Clinical Science, Bournemouth University, Dorset, UK
14Department of Nursing, Laboratory of Integrated Health Care, University of 
Peloponesse, Sparti, Greece
15Medical Faculty, Institute of Health and Nursing Sciences, Martin- Luther- 
Universitat Halle- Wittenberg, Halle (Saale), Germany
16Department of Nursing, Universitat d'Alacant, Alacant, Spain
17Institute of Nursing Sciences, Basic Health Sciences and Health Visiting, University 
of Pecs Faculty of Health Sciences, Pecs, Hungary
18Faculty of Nursing and Professional Health Studies, Slovak Medical University in 
Bratislava, Bratislava, Slovakia
19Faculty of Health Sciences, Department of Nursing, University of Primorska 
College of Health Care, Izola, Slovenia
twitter Elyne De Baetselier @EBaetselier, Bart Van Rompaey @BartRompaey, 
Nienke E Dijkstra @DijkstraNE, Manuel Lillo- Crespo @manuellilloc, Mirko Prosen @
MirkoProsen and Tinne Dilles @TinneDilles
Acknowledgements The authors would like to thank Sabina Ličen (University 
of Primorska), Nia Griffin (Swansea University), Paulo Alexandre Carvalho Ferreira 
(Nursing School of Coimbra), Soraia Alves Rodrigues (Hospital Centre Baixo Vouga), 
Catariana Abrantes da Silva (Hospital Centre Baixo Vouga), Francesco Talarico 
(Pugliese- Ciaccio Hospital), Toke Vanwesemael (University of Antwerp), Filip 
Haegdorens (University of Antwerp), Kelly Sabbe (University of Antwerp) for their 
valuable contribution in collecting data and reviewing the manuscript.
Contributors EDB, BVR, NED, CS, TD contributed to the design of the study. EDB, 
BVR, LMB, MB, BC- P, ADS, NED, MIF, IF, VAG, JH, AKH, MI, SJ, IK, SK, PK, GL, ML- C, 
VL, AM, GM, AO, HP, MP, DP, CS, ST, EZ, TD contributed to the data collection. EDB 
conducted the data analysis. All authors contributed to the interpretation of the 
data, and the preparation and refinement of the final manuscript.
Funding This work was supported by the Erasmus+Programme of the European 
Union (grant number 2018-1- BE02- KA203-046861) and MDMJ accountants, an 
accountancy service in Belgium that financially supported the Belgian authors, 
without any conflicts of interest.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in 
the design, conduct, reporting or dissemination plans of this research.
Patient consent for publication Not required.
ethics approval The Ethics Committee for Social Sciences and Humanities of the 
University of Antwerp approved the study design. Depending on local regulations, 
in some countries additional approval from local organisations: Health Research 
Authority approval and Bournemouth University approval (England), Ethical 
Committee of School of Human Movement and Quality of Life of University of 
Peloponnese (Greece), Health Science Council—Scientific and Research Ethics 
Committee (Hungary), Bioethics Commission at the Medical University of Warsaw 
(Poland), Ethics Committee of the Nursing Sciences Research Unit of the Nursing 
School of Coimbra (Portugal), Integrated Research Application System ethical 
approval and Research & Development departments (Wales).
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available on reasonable request. All data 
relevant to the study are included in the article or uploaded as supplementary 
information.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non- commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non- commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
OrCID iD
Elyne De Baetselier http:// orcid. org/ 0000- 0002- 1586- 7825
reFerenCes
 1 Hepler CD, Strand LM. Opportunities and responsibilities in 
pharmaceutical care. Am J Hosp Pharm 1990;47:533–43.
 2 Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: 
the patient- centered approach to medication management. 3 edn. 
McGraw- Hill Education, 2012.
 3 Kijlstra N, Ridge K, Walser S. Pharmaceutical care: where do we 
stand - where should we go? Key concepts in pharmaceutical care, 
quality assessment of pharmaceutical care in Europe, sources of 
information: survey report. Strasbourg: European Directorate for the 
Quality of Medicines & HealthCare (EDQM), 2009.
 4 Keitel S. Pharmaceutical care – policies and practices for a safer, 
more responsible and cost- effective health system. Strasbourg: 
European Directorate for the Quality of Medicines & HealthCare 
(EDQM), 2012.
 5 Ensing HT, Stuijt CCM, van den Bemt BJF, et al. Identifying the 
optimal role for pharmacists in care transitions: a systematic review. 
J Manag Care Spec Pharm 2015;21:614–36.
 6 Dilles T, Vander Stichele R, Van Rompaey B, et al. Nurses' practices 
in pharmacotherapy and their association with educational level. J 
Adv Nurs 2010;66:1072–9.
 7 Jordan S, Hardy B, Coleman M. Medication management: an 
exploratory study into the role of community mental health nurses. J 
Adv Nurs 1999;29:1068–81.
 o
n
 June 9, 2020 at BVA. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036269 on 3 June 2020. Downloaded from 
12 De Baetselier E, et al. BMJ Open 2020;10:e036269. doi:10.1136/bmjopen-2019-036269
Open access 
 8 Lata PF, Mainhardt M, Johnson CA. Impact of nurse case manager- 
pharmacist collaboration on adverse- drug- event reporting. Am J 
Health Syst Pharm 2004;61:483–7.
 9 Bergqvist M, Ulfvarson J, Andersen Karlsson E, et al. A nurse- led 
intervention for identification of drug- related problems. Eur J Clin 
Pharmacol 2008;64:451–6.
 10 Jordan S, Hughes D. Community teamwork is key to monitoring the 
side- effects of medication. Nurs Times 2000;96:39–40.
 11 Choo J, Hutchinson A, Bucknall T. Nurses' role in medication safety. 
J Nurs Manag 2010;18:853–61.
 12 Thoma JE, Waite MA. Experiences of nurse case managers within a 
central discharge planning role of collaboration between physicians, 
patients and other healthcare professionals: a sociocultural 
qualitative study. J Clin Nurs 2018;27:1198–208.
 13 Maier CB, Aiken LH. Task shifting from physicians to nurses in 
primary care in 39 countries: a cross- country comparative study. Eur 
J Public Health 2016;26:927–34.
 14 Etikan I, Musa S, Alkassim R. Comparison of convenience sampling 
and purposive sampling. AJTAS 2016;5:1–4.
 15 Polit DF, Beck CT. Nursing research: generating and assessing 
evidence for nursing practice. 10 edn. Philadelphia: Wolters Kluwer 
Health,  
2017.
 16 European Commission. The European qualification framework for 
lifelong learning (EQF). Luxembourg: Office for Official Publications of 
the European Communities, 2008.
 17 Kim H- Y. Statistical notes for clinical researchers: assessing normal 
distribution (2) using skewness and kurtosis. Restor Dent Endod 
2013;38:52–4.
 18 Eurostat. Population on 1 January 2018, 2018. Available: https:// ec. 
europa. eu/ eurostat/ tgm/ refreshTableAction. do? tab= table& plugin= 1& 
pcode= tps00001& language= en
 19 World Medical Association. World Medical association declaration 
of Helsinki: ethical principles for medical research involving human 
subjects. JAMA 2013;310:2191–4.
 20 Khan AN, Khan MU, Shoaib MH, et al. Practice nurses and 
pharmacists: a perspective on the expectation and experience of 
nurses for future collaboration. Oman Med J  
2014;29:271–5.
 21 Wang S- P, Wang J, Huang Q- H, et al. Pharmacy and nursing 
students' attitudes toward nurse- pharmacist collaboration at a 
Chinese university. BMC Med Educ 2018;18:179.
 22 Feldman LS, Costa LL, Feroli ER, et al. Nurse- pharmacist 
collaboration on medication reconciliation prevents potential harm. J 
Hosp Med 2012;7:396–401.
 23 While A, Shah R, Nathan A. Interdisciplinary working between 
community pharmacists and community nurses: the views of 
community pharmacists. J Interprof Care 2005;19:164–70.
 24 Celio J, Ninane F, Bugnon O, et al. Pharmacist- nurse collaborations 
in medication adherence- enhancing interventions: a review. Patient 
Educ Couns 2018;101:1175–92.
 25 Wilson AJ, Palmer L, Levett- Jones T, et al. Interprofessional 
collaborative practice for medication safety: nursing, pharmacy, and 
medical graduates' experiences and perspectives. J Interprof Care 
2016;30:649–54.
 26 Azhar S, Hassali MA, Mohamed Ibrahim MI, et al. A survey 
evaluating nurses' perception and expectations towards the 
role of pharmacist in Pakistan's healthcare system. J Adv Nurs 
2012;68:199–205.
 27 Reeves S, Pelone F, Harrison R, et al. Interprofessional collaboration 
to improve professional practice and healthcare outcomes. Cochrane 
Database Syst Rev 2017;6:Cd000072.
 28 Dinius J, Gaupp R, Becker S, et al. Patient safety in hospitals: 
what we do and what we need- focus groups with stakeholders of 
hospitals in southern Germany. J Patient Saf 2017. doi:10.1097/
PTS.0000000000000452. [Epub ahead of print: 15 Dec 2017].
 29 Jordan S, Logan PA, Panes G, et al. Adverse drug reactions, 
power, harm reduction, regulation and the ADRe profiles. Pharmacy 
2018;6:102.
 30 Müller M, Jürgens J, Redaèlli M, et al. Impact of the communication 
and patient hand- off tool SBAR on patient safety: a systematic 
review. BMJ Open 2018;8:e022202.
 31 Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions 
as cause of admission to hospital: prospective analysis of 18 820 
patients. BMJ 2004;329:15–19.
 32 Ebert L, Hoffman K, Levett- Jones T, et al. "They have no idea of 
what we do or what we know": Australian graduates' perceptions of 
working in a health care team. Nurse Educ Pract 2014;14:544–50.
 o
n
 June 9, 2020 at BVA. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-036269 on 3 June 2020. Downloaded from 
